U.S. Patent 7717948 was awarded to Ardian, Inc. on 2010-05-18 and describes a “Methods and apparatus for thermally-induced renal neuromodulation.” This patent has been cited 295 times by other U.S. patents which places it in the top 500 cited patents since 2010 according to our law firm research, and makes it of the most innovative medical technology patents in the field of instruments. The abstract states:

Methods and apparatus are provided for thermally-induced renal neuromodulation. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers. In some embodiments, parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors for controlling the thermally-induced neuromodulation. In some embodiments, protective elements may be provided to reduce a degree of thermal damage induced in the non-target tissues. Link: U.S. Patent 7717948

This patent was originally filed on 2007-08-16 which gives it a processing time of 1006 days, compared to an average processing time of 1644 in the field. Ardian, Inc. has 29 total patents. The first named inventor is Mark Gelfand of New York, NY. The primary examiner was Roy D Gibson.

Select Patents monitors top medical technology patents and instruments patents which have been allowed and granted worldwide. If you would like legal advice regarding a patent or would like to file a patent go to https://selectpatents.wpengine.com/contact/